Search clinical trials for: 68Ga-RM26-RGD

Total 2306 results

Peking Union Medical College Hospital

Recruiting

68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients

Breast Cancer | Prostate Cancer | Brain Tumor | PET/CT Imaging

China
Peking Union Medical College Hospital

Recruiting

68Ga-NOTA-RM26 PET/CT in Glioma Patients

Glioma

China
Karolinska University Hospital
Uppsala University; Stockholm South General Hospital

Recruiting

68Ga-NOTA-PEG2-RM26 PET/CT, First in Man Study

Cancer

Sweden
Lightpoint Medical Limited

Not yet recruiting

The LightPath® and 68Ga-RM2 in Breast Cancer Study

Breast Cancer

United Kingdom
Peking Union Medical College Hospital

Recruiting

68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients

Lung Neoplasms

China
Peking Union Medical College Hospital
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Unknown

Dual Integrin αvβ3 and GRPR Targeting PET Imaging in Breast Cancer Patients

Breast Cancer

China
Peking Union Medical College Hospital
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Unknown

68Ga-NOTA-BBN-RGD PET/CT in Prostate Cancer Patients

Prostate Cancer

China
Peking Union Medical College Hospital

Unknown

68Ga-NOTA-RM26 PET/CT in Breast Tumor Patients

Breast Tumor

China
Turku University Hospital
University of Lausanne Hospitals; Leiden University Medical Center

Recruiting

68Ga-NODAGA-RGD PET in Patients With an Occluded Coronary Artery (RGDHeart)

Coronary Artery Disease

Finland, Netherlands, Switzerland
Memorial Sloan Kettering Cancer Center

Completed

68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate Cancer

Prostate Cancer

United States
Peking Union Medical College Hospital
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Unknown

68Ga-NOTA-RM26 PET/CT in Prostate Cancer Patients

Prostate Cancer

China
Peking Union Medical College Hospital

Recruiting

68Ga-NOTA-RM26 PET/CT for the Detection of Gastrointestinal Stromal Tumor

Gastrointestinal Stromal Tumors

China
Peking Union Medical College Hospital

Recruiting

Diagnosis of Metastatic Tumors on 68Ga-FAPI-RGD PET-CT and Radioligand Therapy With 177Lu-FAPI-RGD

FAP- Expressing Positive Tumors | RGD- Expressing Positive Tumors

China
First Affiliated Hospital of Fujian Medical University

Recruiting

68Ga-FAP-RGD PET/CT : Dosimetry and Preliminary Clinical Translational Studies

Tumor

China
Rigshospitalet, Denmark

Completed

68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Myocardial Angiogenesis

Acute Myocardial Infarction

Denmark
Novartis Pharmaceuticals
Eckert & Ziegler Radiopharma GmbH

Completed

A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan

Neuroendocrine Neoplasms

Japan
Rigshospitalet, Denmark

Not yet recruiting

68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Angiogenesis in Ischemic Heart Disease

Chronic Ischemic Heart Disease

Denmark
University of Lausanne Hospitals
Swiss Heart Foundation

Recruiting

Multimodal Imaging Assessment of the Inflammatory Atheromatous Plaque

Inflammation | Carotid Artery Diseases | Atheromatous Plaques

Switzerland
Peking Union Medical College Hospital

Recruiting

Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging

Lung Cancer | Neuroendocrine Neoplasm

China
Radboud University Medical Center

Completed

RGD PET/CT Imaging in COVID-19 Patients

Covid19 | Endothelial Dysfunction | PET Imaging

Netherlands
IRCCS San Raffaele

Recruiting

PET/MRI to Stage Prostate Cancer Patients

Prostate Cancer

Italy
Peking Union Medical College Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Myocardial Infarction (GRGDMI)

Coronary Artery Disease

China
Peking Union Medical College Hospital
Beijing Tiantan Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of Glioma (GRGDG)

Glioma

China
Life Molecular Imaging SA

Terminated

PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer

Prostate Cancer

Austria, Finland
Peking Union Medical College Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Healthy Volunteers and Lung Cancer Patients (GRGDLC)

Lung Cancer

China
Huashan Hospital

Recruiting

A Study of [68Ga]Ga-NOTA-RG2 PET Imaging in the Diagnosis of Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
IRCCS San Raffaele

Completed

PET/MR for Prostate Cancer Restaging: a Phase II Prospective Monocentric Study

Prostate Cancer

Italy
Siemens Molecular Imaging

Terminated

[F-18] RGD-K5 Positron Emission Tomography (PET) in Participants With Carotid Artery Stenosis

Carotid Stenosis

United States
Peking Union Medical College Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Patients With Rheumatoid Arthritis (GRGDRA)

Rheumatoid Arthritis

China
University Hospital, Bordeaux

Completed

68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Intermediate Risk Prostate Cancer Imaging (PROSTATEP)

Prostate Cancer

France
Rigshospitalet, Denmark

Unknown

Radiation Therapy Planning by Multi-parametric PET/MRI Imaging in Patients With Cervical Cancer (RaPiCCa)

Cervical Cancer

Denmark
University Hospital, Bordeaux

Completed

68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic Risks (UROPET)

Prostate Cancer

France
Peking Union Medical College Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Stroke (GRGDS)

Stroke

China
Andrei Iagaru

Completed

68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer

Prostate Adenocarcinoma

United States
University of Lausanne Hospitals

Terminated

Study of Cardiac Lesions Angiogenesis by 68Ga-NODAGA-RGD Cardiac PET

Myocardial Infarction, Acute | Chronic Ischemic Heart Disease | Myocardial Reperfusion

Switzerland
Peking Union Medical College Hospital

Recruiting

A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors

Meningioma | NETs | Iodine-resistant Thyroid Cancer

China
Tel Aviv University
Wolfson Medical Center

Completed

Effects of Red Grape Cells (RGC) Powder in Type 2 Diabetics (RGC-T2D)

Type 2 Diabetes

Israel
The First Affiliated Hospital of Xiamen University

Completed

68Ga-FAPI-RGD PET/CT for Dual Integrin αvβ3 and FAP-targeted Imaging in Patients With Various Types of Cancer and Compared With 18F-FDG

Positron-Emission Tomography | Tumor, Solid

China
Assistance Publique - Hôpitaux de Paris

Terminated

PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic Agents (MLAPOCHI)

Advanced Head and Neck Carcinoma | Advanced Non-small Cell Lung Carcinoma

France
Xijing Hospital

Completed

68Ga-AlfatideII for the Differential Diagnosis of of Lung Cancer and Lung Tuberculosis by PET/CT

Lung Cancer | Lung Tuberculosis
Tomsk National Research Medical Center of the Russian...
Uppsala University

Completed

Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m RM26

Prostate Cancer | Breast Cancer Female

Russian Federation
Andrei Iagaru
General Electric

Completed

68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer

Prostate Cancer

United States
University of Lausanne Hospitals
George Coukos, MD PhD, Head of oncology

Terminated

68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis

Pathological Angiogenesis

Switzerland
Peking Union Medical College Hospital

Recruiting

68Ga-pentixather and 68Ga-pentixafor PET/CT in Multiple Myeloma

Multiple Myeloma

China
Pentixapharm AG

Terminated

[68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients

CNS Lymphoma

Denmark, France
Peking University Cancer Hospital & Institute
Peking University Health Science Center

Recruiting

68Ga-ICAM-1pep PET/CT in Cancer Patients

Cancer

China
Xiangya Hospital of Central South University

Completed

Clinical Translation of a Novel FAPI Dimer [68Ga]Ga-LNC1013

Gastrointestinal Cancer

China
Novartis Pharmaceuticals

Not yet recruiting

Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors

Non-small Cell Lung Cancer (NSCLC) | Triple Negative Breast Cancer (TNBC) | Colorectal Cancer (CRC) | Soft Tissue Sarcoma (STS) | Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) | HR+/HER2- Ductal Breast Cancer (BC) | HR+/HER2- Lobular Breast Cancer (BC)
First Affiliated Hospital of Fujian Medical University

Recruiting

The Value of GRPR PET Imaging for Diagnosis and Staging in Prostate Cancer

Prostate Cancer (Adenocarcinoma)

China
Memorial Sloan Kettering Cancer Center
Pentixapharm AG

Recruiting

In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET

Multiple Myeloma | Non-Hodgkin Lymphoma | Erdheim-Chester Disease | Rosai-Dorfman Disease | Histiocytic Neoplasms

United States

Search clinical trials for: 68Ga-RM26-RGD

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations